Breakthrough medicines unlocking the biology of heme
Company is active
Event Year: 2024
Company is active
Event Year: 2024
Velorum Therapeutics is dedicated to the development of innovative pharmaceutical solutions. Their approach centers on a deep understanding of heme biology, leveraging this knowledge to create groundbreaking medicines with the potential to transform patient care and address unmet medical needs. By focusing on the intricacies of heme, Velorum aims to unlock new therapeutic pathways and deliver significant advancements in the healthcare landscape.
Velorum Therapeutics is dedicated to the development of innovative pharmaceutical solutions. Their approach centers on a deep understanding of heme biology, leveraging this knowledge to create groundbreaking medicines with the potential to transform patient care and address unmet medical needs. By focusing on the intricacies of heme, Velorum aims to unlock new therapeutic pathways and deliver significant advancements in the healthcare landscape.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2024
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2024
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 5
Hiring: No
Team size: 5
Hiring: No